Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Current evidence and future directions for KIM-1 as a blood-based biomarker in RCC.
Journal: Nature reviews. Clinical oncology
Published: May 20, 2026
Estimate renal cell carcinoma recurrence rates using electronic health records.
Journal: ESMO real world data and digital oncology
Published: April 22, 2026
A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell Carcinoma.
Journal: Cancers
Published: February 08, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0.
Journal: Journal for immunotherapy of cancer
Published: February 01, 2026
KIM-1 in Advanced Papillary and Clear Cell Renal Cell Carcinoma.
Journal: European urology
Published: December 08, 2025
KIM-1 in Advanced Papillary and Clear Cell Renal Cell Carcinoma.
Journal: European urology
Published: December 08, 2025
Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma.
Journal: European urology
Published: October 03, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
LASER: A Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for RCC.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 13, 2025
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.
Journal: European urology
Published: September 12, 2025
Dual Inhibition of CDK4/6 and mTORC1 Establishes a Preclinical Strategy for Translocation Renal Cell Carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2025
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 31, 2025
Last Updated: 09/26/2026